Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style.
Abstract | OBJECTIVE: METHODS: We reviewed available evidence on risk factors and means of modifying them to prevent ischaemic stroke and TIA. Levels of evidence and recommendation grades are based on the classification of the Centre for Evidence-Based Medicine. RESULTS: CONCLUSIONS:
|
Authors | B Fuentes, J Gállego, A Gil-Nuñez, A Morales, F Purroy, J Roquer, T Segura, J Tejada, A Lago, E Díez-Tejedor, M Alonso de Leciñana, J Alvarez-Sabin, J Arenillas, S Calleja, I Casado, M Castellanos, J Castillo, A Dávalos, F Díaz-Otero, J A Egido, J C López-Fernández, M Freijo, A García Pastor, F Gilo, P Irimia, J Maestre, J Masjuan, J Martí-Fábregas, P Martínez-Sánchez, E Martínez-Vila, C Molina, F Nombela, M Ribó, M Rodríguez-Yañez, F Rubio, J Serena, P Simal, J Vivancos, Comitéad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN |
Journal | Neurologia (Barcelona, Spain)
(Neurologia)
2012 Nov-Dec
Vol. 27
Issue 9
Pg. 560-74
ISSN: 1578-1968 [Electronic] Spain |
PMID | 21890241
(Publication Type: Guideline, Journal Article)
|
Copyright | © 2011 Sociedad Española de Neurología. Published by Elsevier Espana. All rights reserved. |
Topics |
- Brain Ischemia
(epidemiology, prevention & control)
- Evidence-Based Medicine
- Humans
- Ischemic Attack, Transient
(epidemiology, prevention & control)
- Life Style
- Risk Factors
- Spain
(epidemiology)
- Stroke
(epidemiology, prevention & control)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|